Univariate and multivariate analysis for OS in PMF patients
| . | Hazard ratio (95% CI) . | P . |
|---|---|---|
| Univariate | ||
| Male sex | 0.547 (0.358-0.835) | .005 |
| IPSS score | 4.807 (2.807-8.232) | < .0001 |
| Platelet count < 100 × 109/L | 0.999 (0.998-0.999) | < .0001 |
| EZH2 mutation | 2.817 (1.565-5.072) | .001 |
| V617F burden < 25% | 2.256 (1.034-4.921) | .040 |
| Multivariate | ||
| IPSS score | 6.087 (2.723-13.606) | < .0001 |
| EZH2 mutation | 3.585 (1.274-10.091) | .016 |
| V617F burden < 25% | 1.082 (1.014-1.101) | .046 |
| . | Hazard ratio (95% CI) . | P . |
|---|---|---|
| Univariate | ||
| Male sex | 0.547 (0.358-0.835) | .005 |
| IPSS score | 4.807 (2.807-8.232) | < .0001 |
| Platelet count < 100 × 109/L | 0.999 (0.998-0.999) | < .0001 |
| EZH2 mutation | 2.817 (1.565-5.072) | .001 |
| V617F burden < 25% | 2.256 (1.034-4.921) | .040 |
| Multivariate | ||
| IPSS score | 6.087 (2.723-13.606) | < .0001 |
| EZH2 mutation | 3.585 (1.274-10.091) | .016 |
| V617F burden < 25% | 1.082 (1.014-1.101) | .046 |